IDV vehicle

36E79726D0035

NEW AWARD FOR VENLAFAXINE HYDROCHLORIDE (HCL) 24HR SUSTAINED ACTION (SA) CAPSULES WITH PURACAP LABORATORIES, LLC DBA BLU PHARMACEUTICALS. PERIOD OF PERFORMANCE IS AUG. 30, 2026 TO AUG. 29, 2026 WITH FOUR ONE-YEAR OPTIONS.

Research the contractorView USAspending sourceSave to my pursuit research

Award details

Obligations, current value and potential value describe different measures; they are never added together.

FieldReported value
AgencyDepartment of Veterans Affairs
OfficeNAC PHARMACEUTICALS (36E797)
NAICS325412 — Pharmaceutical Preparation Manufacturing
PSC6505 — Drugs and Biologicals
Parent award / vehicleNot reported
Set-asideNO SET ASIDE USED.
Pricing typeFIRM FIXED PRICE
Obligations$0
Current contract valueNot reported
Potential contract value / ceiling$32.4M
Start dateAug 30, 2026
Current end dateNot available
Potential end dateNot available
Latest award activitySep 11, 2026
Source loadedSep 26, 2026

Funding and modification history

Showing the latest 2 of 2 loaded transactions. Negative values are deobligations.

DateModificationObligation changeDescription
Sep 11, 2026P00001$0IMPLEMENTATION OF EXECUTIVE ORDER 14398
Jun 24, 20260$0NEW AWARD FOR VENLAFAXINE HYDROCHLORIDE (HCL) 24HR SUSTAINED ACTION (SA) CAPSULES WITH PURACAP LABORATORIES, LLC DBA BLU PHARMACEUTICALS. PERIOD OF PERFORMANCE IS AUG. 30, 2026 TO AUG. 29, 2026 WITH FOUR ONE-YEAR OPTIONS.

Buyer contacts from matching notices

Matched on exact award/solicitation identifier and awarding agency. Source dates describe the notice, not current contact verification.

ContactRolePublished contact methodsEvidenceSource date
Andrew J CazaresContract SpecialistAndrew.Cazares@va.govSourceMar 31, 2026
Andrew J CazaresContract SpecialistAndrew.Cazares@va.govSourceMar 24, 2026
Andrew J CazaresContract SpecialistAndrew.Cazares@va.govSourceMar 11, 2026
Andrew CazaresContract Specialistandrew.cazares@va.gov
(708)786-4990
SourceFeb 5, 2026

Research next steps

  1. Check the stated set-aside against the solicitation and current certifications.
  2. Review the award scope and buyer evidence before making a bid/no-bid decision.